Decreased expression of α2,8 sialyltransferase and increased expression of β1,4 N-acetylgalactosaminyltransferase in gastrointestinal cancers

Experimental Biology and Medicine

Volumn 227, Issue 3, 2002, Pages 196-200

  Koh, Yasuhiro ^a   Tsunoda, Takuya ^c   Iwahashi, Makoto ^b   Yamaue, Hiroki ^b   Ishimoto, Kiwao ^b   Tanimura, Hiroshi ^b   Fukumoto, Hisao ^a   Nakamura, Takashi ^a   Tatsumi, Yasuaki ^a   Shimizu, Mikiko ^a   Saijo, Nagahiro ^a   Nishio, Kazuto ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Ganglioside; Gastrointestinal cancer; 2,8 sialyltransferase; 1,4 N acetylgalactosaminyltransferase

Indexed keywords

ALPHA 2,8 SIALYLTRANSFERASE; BETA 1,4 N ACETYLGALACTOSAMINYLTRANFERASE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; MESSENGER RNA; SYNTHETASE; UNCLASSIFIED DRUG; (N ACETYLNEURAMINYL) GALACTOSYLGLUCOSYLCERAMIDE N ACETYLGALACTOSAMINYLTRANSFERASE; (N-ACETYLNEURAMINYL)-GALACTOSYLGLUCOSYLCERAMIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; BETA D GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; GANGLIOSIDE; N ACETYLGALACTOSAMINYLTRANSFERASE; SIALYLTRANSFERASE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CELL SURFACE; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR DIFFERENTIATION; BIOSYNTHESIS; COLORECTAL TUMOR; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; SEX DIFFERENCE; STOMACH TUMOR;

ADULT; AGED; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GANGLIOSIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; SEX FACTORS; SIALYLTRANSFERASES; STOMACH NEOPLASMS;

EID: 0036514174     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700307     Document Type: Article

References (25)

1. Portoukalian J, Zwingelstein G, Dore JF. Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur J Biochem 94:19-23, 1979.
2. Yates AJ, Thompson DK, Boesel CP, Albrightson C, Hart RW. Lipid composition of human neural tumors. J Lipid Res 20:428-436, 1979.
3. Bajorin DF, Chapman PB, Wong G, Coit DG, Kunicka J, Dimaggio J, Cordon-Cardo C, Urmacher C, Dantes L, Templeton MA, Liu J, Oettgen HF, Houghton AN. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res 50:7490-7495, 1990.
4. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A 82:1242-1246, 1985.
5. Minasian LM, Yao TJ, Steffens TA, Scheinberg DA, Williams L, Riedel E, Houghton AN, Chapman PB. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer 75:2251-2257, 1995.
6. Uttenreuther-Fischer MM, Huang CS, Yu AL. Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients. Cancer Immunol Immunother 41:331-338, 1995.
7. Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N. Chimeric anti-ganglioside GM2 antibody with antitumor activity. Cancer Res 54:1511-1516, 1994.
8. Fukumoto H, Nishio K, Ohta S, Hanai N, Saijo N. Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody. Int J Cancer 67:676-680, 1996.
9. Fukumoto H, Nishio K, Ohta S, Hanai N, Fukuoka K, Ohe Y, Sugihara K, Kodama T, Saijo N. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo. Int J Cancer 82:759-764, 1999.
10. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 265:1287-1289, 1991.
11. Powell J. McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62:440-443, 1990.
12. Engstrom PF, Lavin PT, Douglass HO Jr, Brunner KW. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Cancer 55:1868-1873, 1985.
13. Higgins GA, Amadeo JH, Smith DE, Humphrey EW, Keehn RJ. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma: a Veterans Administration Surgical Oncology Group Report. Cancer 15:1105-1112, 1983.
14. Haraguchi M, Yamashiro S, Yamamoto A, Furukawa K, Takamiya K, Lloyd KO, Shiku H, Furukawa K. Isolation of GD3 synthase by expression cloning of GM3 α-2, 8-sialyl transferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci U S A 91:10455-10459, 1994.
15. A2 synthesis for utilization of lactosylceramide substrate in vivo. J Biol Chem 269:29227-29231, 1994
16. D2 gangliosides. J Biol Chem 267:12082-12089, 1992
17. D2 gangliosides. J Biol Chem 269:7054, 1994
18. Ruan S, Raj BK, Lloyd KO. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J Neurochem 72:514-521, 1999.
19. Kinoshita T, Imamura J, Nagai H, Shimotohno K. Quantification of gene expression over a wide range by the polymerase chain reaction. Anal Biochem 206:231-235, 1992.
20. Anic M, Mesaric M. The influence of sex steroid hormones on ganglioside biosynthesis in rat kidney. Biol Chem 379:693-697, 1998.
21. Yuyama Y, Dohi T, Morita H, Furukawa K, Oshima M. Enhanced expression of GM2/GD2 synthase mRNA in human gastrointestinal cancer. Cancer 75:1273-1280, 1995.
22. Hakomori S. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 3:646-653, 1991.
23. Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo, K. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol 102:688-696, 1986.
24. Kaur G, Viallet J, Laborda J, Blair O. Gazdar AF, Minna JD. Sausville EA. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GMI ganglioside expression. Cancer Res 52:3340-3346, 1992.
25. Nakamura K, Hanibuchi M, Yano S, Tanaka Y, Fujino I. Inoue M, Takezawa T, Shitara K, Sone S, Hanai N. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody. Cancer Res 59:5323-5330, 1999.